Meeting
Abstract Number: 186
SHM Converge 2024
Background: Patients undergoing cardiac surgery are at risk of anemia from blood loss, inflammation, and red blood cell lysis, necessitating blood product utilization and increasing the risk of post-operative complications. RBT-1 (a combination of stannic protoporfin and iron sucrose) is a novel preconditioning drug administered prior to surgery that upregulates anti-inflammatory, antioxidant, and iron scavenging [...]
Abstract Number: 194
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Controversy still exists regarding the use of angiotensin axis blockade (AAB) with angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) drugs preoperatively. Multiple studies suggest the AAB results in acute kidney injury (AKI) (1,2), while other studies do not (3,4 ). Some studies suggest that the AKI associated with AAB is due [...]
Abstract Number: 0667
SHM Converge 2025
Case Presentation: A 70-year-old with a hyperlipidemia, diabetes, coronary artery disease, heart failure with mildly reduced ejection fraction and vascular dementia was admitted to the Orthopaedic Surgery service after a fall sustaining a femoral neck fracture. On assessment by the Hospital Medicine consultation service, the patient had clear lungs and no cardiac murmurs. Admission labs [...]